IL1B and Behcet disease: Similar results were presented in the most recent review by Odeya Damri and Galila Agam [126], showing that chronic lithium treatment leads to altered cytokines expression in BD patients, decreases the secretion of inflammatory mediators in peripheral blood leukocytes, and also reduces the secretion of IL-1β in monocytes in vitro.